Guangzhou Jet Biofiltration Hits Day Low of CNY 14.71 Amid Price Pressure

Guangzhou Jet Biofiltration Co., a small-cap player in the Pharmaceuticals & Biotechnology sector, experienced a significant decline today, with its stock price dropping by 9.38%. The stock reached an intraday low of CNY 14.71, reflecting a challenging trading environment. Over the past week, the company has seen a 17.06% decrease, and its performance over the last month has been even more pronounced, with a decline of 20.67%. Year-to-date, the stock is down 8.26%, contrasting sharply with the China Shanghai Composite, which has shown a lesser decline of 3.92% during the same period. Long-term growth metrics indicate that Guangzhou Jet Biofiltration has faced difficulties, with net sales growing at an annual rate of only 3.95% and operating profit declining by 7.83% over the last five years. The company's inventory turnover ratio stands at a low 2.65 times, and its interest coverage ratio is at its lowest point of 274.23. These indicators suggest that the company is navigating a challenging landscape within its industry.